During the past decade, Broward Oncology Associates conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Broward Oncology Associates" #1 sponsor was "CTI BioPharma" with 4 trials, followed by "Celgene" with 3 trials sponsored, "Telik" with 2 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored and "Cepheid" with 1 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Broward Oncology Associates" #1 collaborator was "Bionomics Limited" with 1 trials as a collaborator, "ICON Clinical Research" with 1 trials as a collaborator, "Janssen, LP" with 1 trials as a collaborator, "Quintiles, Inc." with 1 trials as a collaborator and "Sanofi" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Broward Oncology Associates" are "Multiple Myeloma" (2 trials), "NSCLC" (2 trials), "Adult Solid Tumor" (1 trials), "Chronic Lymphocytic Leukemia (CLL)" (1 trials) and "Chronic Myeloid Leukemia" (1 trials). Many other conditions were trialed in "Broward Oncology Associates" in a lesser frequency.

Most popular intervention types in "Broward Oncology Associates" are "Drug" (13 trials), "Biological" (1 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "paclitaxel" (2 trials), "paclitaxel poliglumex" (2 trials), "5-FU/cisplatin" (1 trials), "BNC105P" (1 trials) and "Bortezomib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Broward Oncology Associates" are 17 trials for "All" genders, 3 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Broward Oncology Associates". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Broward Oncology Associates, 1 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Broward Oncology Associates, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".